An act relating to adding xylazine to the list of regulated drugs

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 1 Sponsors 8

PASSAGE PROBABILITY

4.1% Unlikely

Why this number

Stage base Introduced — base rate 11%, measured from VT's completed sessions
Momentum -4 32/100 from the pace of recorded action
Time since last action -22 955 days quiet
Cosponsors +10 7 signed on
Bipartisan support +9 4 D · 1 I · 3 R

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.